Kamada (NASDAQ:KMDA) Coverage Initiated by Analysts at Benchmark
Benchmark initiated coverage on shares of Kamada (NASDAQ:KMDA – Free Report) in a research report released on Friday morning, MarketBeat reports. The brokerage issued a buy rating and a $15.00 target price on the biotechnology company’s stock. A number of other brokerages have also recently issued reports on KMDA. HC Wainwright reissued a “buy” rating […]
